论文信息 - I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure.

I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure.

Edimar Alcides Bocchi, Fabio Vilas-Boas, Sergio Perrone, Angel G Caamano, Nadine Clausell, Maria da Consolacao VMoreira, Jorge Thierer, Hugo Omar Grancelli, Carlos Vicente Serrano Junior, Denilson Albuquerque, Dirceu Almeida,Fernando Bacal, Luis Felipe Moreira, Adonay Mendonza, Antonio Magana, Arturo Tejeda, Daniel Chafes, Efraim Gomez,Erick Bogantes, Estela Azeka, Evandro Tinoco Mesquita, Francisco Jose Farias B Reis, Hector Mora, Humberto Vilacorta,Jesus Sanches, Joao David de Souza Neto, Jose Luis Vuksovic, Juan Paes Moreno, Julio Aspe y Rosas, Lidia ZytynskiMoura, Luis Antonio de Almeida Campos, Luis Eduardo Rohde, Marcos Parioma Javier, Martin Garrido Garduno, MucioTavares, Pablo Castro Galvez, Raul Spinoza, Reynaldo Castro de Miranda, Ricardo Mourilhe Rocha, Roberto Paganini,Rodolfo Castano Guerra, Salvador Rassi, Sofia Lagudis, Solange Bordignon, Solon Navarette, Waldo Fernandes, AntonioCarlos Pereira Barretto, Victor Issa, Jorge Ilha Guimaraes.

[1] G. Kay,et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[2] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[3] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[4] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[5] J. McMurray,et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[6] M. Metra,et al. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. , 1994, American heart journal.

[7] William A. Knaus,et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. , 1996, Journal of the American Medical Association (JAMA).

[8] B. Griffin,et al. Current medical management of valvular heart disease. , 2001, Cleveland Clinic journal of medicine.

[9] C. Hinds,et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.

[10] J. Cleland,et al. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL , 2002, European journal of heart failure.

[11] M. Fishbein,et al. Ventricular septal rupture after acute myocardial infarction. , 2002, The New England journal of medicine.

[12] L Goldman,et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.

[13] L. Erhardt,et al. Organisation of the care of patients with heart failure , 1998, The Lancet.

[14] Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. , 1973 .

[15] C. Fonseca,et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study , 2002, European journal of heart failure.

[16] M. Acker. Mechanical circulatory support for patients with acute-fulminant myocarditis. , 2001, The Annals of thoracic surgery.

[17] R. D. dos Santos,et al. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease. , 2004, Arquivos brasileiros de cardiologia.

[18] K. H. Martens,et al. A study of the relationship between home care services and hospital readmission of patients with congestive heart failure. , 1997, Home healthcare nurse.

[19] C. H. Lockwood. Diuretic therapy. , 1961, Medical services journal, Canada.

[20] C. O'connor,et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. , 2003, American heart journal.

[21] Josef Niebauer,et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study , 1999, The Lancet.

[22] M. Hammond,et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[23] Effect of carvedilol on survival in severe chronic heart failure. , 2001 .

[24] Y Wang,et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[25] W. Shoemaker,et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.

[26] L. Benson,et al. Diagnosis and Management of Pediatric Myocarditis , 2002, Paediatric drugs.

[27] U. Sechtem,et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. , 1995, Circulation.

[28] O. Hess,et al. Intracardiac Angiotensin‐Converting Enzyme Inhibition Improves Diastolic Function in Patients With Left Ventricular Hypertrophy due to Aortic Stenosis , 1994, Circulation.

[29] W. Abraham,et al. Specialized centers for heart failure management. , 1997, Circulation.

[30] S. Lundin,et al. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31] T. LeJemtel,et al. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. , 1993, American heart journal.

[32] Simon Stewart,et al. Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.

[33] K. Sliwa,et al. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 2002, The American journal of cardiology.

[34] J. Ramires,et al. Efeitos do carvedilol (bloqueador b1,b2,a 1) na insuficiência cardíaca refratária , 1998 .

[35] Robert Wolk,et al. Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea , 2002, Circulation.

[36] M. Nieminen,et al. Randomized study on safety and effectiveness of levosimendan in patients with left ventricular failure after an acute myocardial infarct , 1999 .

[37] M. Artman,et al. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. , 2001, The Journal of pediatrics.

[38] I. Shapira,et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[39] G. Fonarow,et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. , 1997, Circulation.

[40] B. Uretsky,et al. Mitral regurgitation following acute myocardial infarction. , 2002, Coronary artery disease.

[41] J. Forrester,et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. , 1973, The New England journal of medicine.

[42] G. J. Crystal,et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. , 1993, The American journal of physiology.

[43] S. Taylor,et al. HAEMODYNAMIC ADVANTAGES OF ISOSORBIDE DINITRATE OVER FRUSEMIDE IN ACUTE HEART-FAILURE FOLLOWING MYOCARDIAL INFARCTION , 1983, The Lancet.

[44] N. Dawson,et al. Hemodynamic status in critically ill patients with and without acute heart disease. , 1990, Chest.

[45] Jeroen J. Bax,et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. , 1999, Journal of the American College of Cardiology.

[46] S. Goldsmith,et al. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. , 1993, The American journal of medicine.

[47] R. Weiss,et al. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. , 1996, American heart journal.

[48] J S Child,et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.

[49] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[50] G. Fonarow,et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. , 1997, Journal of the American College of Cardiology.

[51] S. Colan,et al. Congestive heart failure in pediatric patients. , 2001, American heart journal.

[52] R. Carney,et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[53] W. Grossman. Defining diastolic dysfunction. , 2000, Circulation.

[54] D. Wessel,et al. Managing low cardiac output syndrome after congenital heart surgery. , 2001, Critical care medicine.

[55] E. Azeka,et al. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. , 2002, Journal of the American College of Cardiology.

[56] J R Wilson,et al. Effect of a heart failure program on hospitalization frequency and exercise tolerance. , 1997, Circulation.

[57] F J Ten Cate,et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.

[58] L. Iorio. Daily Hemofiltration in Severe Heart Failure , 1997, Kidney international. Supplement.

[59] S. Gottlieb,et al. Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure , 2000, Circulation.

[60] J. Gardin,et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .

[61] E. Bocchi,et al. Growth hormone for optimization of refractory heart failure treatment. , 1999, Arquivos brasileiros de cardiologia.

[62] A. Burger,et al. Concomitant beta-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure. , 2002, Journal of cardiac failure.

[63] G. Ayers,et al. Reversible Impairment of Left and Right Ventricular Systolic and Diastolic Function During Short‐Lasting Atrial Fibrillation in Patients with an Implantable Atrial Defibrillator: A Tissue Doppler Imaging Study , 2001, Pacing and clinical electrophysiology : PACE.

[64] Alan S Maisel,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[65] U. Elkayam,et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.

[66] D. Mann,et al. The role of cytokines in disease progression in heart failure. , 1997, Current opinion in cardiology.

[67] Sheldon H Gottlieb,et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. , 2002, Journal of the American College of Cardiology.

[68] N. Hertzer. Fatal myocardial infarction following peripheral vascular operations. A study of 951 patients followed 6 to 11 years postoperatively. , 1982, Cleveland Clinic quarterly.

[69] C. Grupi,et al. Noninvasive diagnosis of allograft vascular disease after heart transplantation. , 2001, Arquivos brasileiros de cardiologia.

[70] A. L'Abbate,et al. Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.

[71] M. Rubenfire,et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. , 1973, The New England journal of medicine.

[72] R. Cooper,et al. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. , 1988, Archives of internal medicine.

[73] J. Ramires,et al. [Effects of carvedilol (beta 1, beta 2, alpha 1 bloker) on refractory congestive heart failure]. , 1998, Arquivos brasileiros de cardiologia.

[74] J. Port,et al. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. , 1990, Circulation.

[75] Shuiping Zhao,et al. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy. , 1999, International journal of cardiology.

[76] Daly Pa,et al. Myocardial catecholamines and the pathophysiology of heart failure. , 1990 .

[77] L. Cohn,et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. , 1987, Circulation.

[78] Kenneth E Wood,et al. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. , 2002, Chest.

[79] D. BlannAndrew,et al. Venous thromboembolism , 2006, BMJ : British Medical Journal.

[80] Simon Stewart,et al. Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study , 1999, The Lancet.

[81] F. Abboud,et al. Sympathetic-nerve activity during sleep in normal subjects. , 1993, The New England journal of medicine.

[82] F. Russel,et al. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. , 1996, Journal of the American College of Cardiology.

[83] P. Agostoni,et al. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. , 1996, The American journal of medicine.

[84] Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery , 1999 .

[85] L. U. G. Attinoni,et al. A TRIAL OF GOAL-ORIENTED HEMODYNAMIC THERAPY IN CRITICALLY ILL PATIENTS , 2000 .

[86] J. Wahr. Myocardial ischaemia in anaemic patients. , 1998, British journal of anaesthesia.

[87] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[88] W. Weintraub,et al. Cost and cost-effectiveness studies in heart failure research. , 2002, American heart journal.

[89] R. Brant,et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. , 2003, The New England journal of medicine.

[90] H. Schunkert,et al. Distribution and Functional Significance of Cardiac Angiotensin Converting Enzyme in Hypertrophied Rat Hearts , 1993, Circulation.

[91] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.

[92] J. Cleland,et al. Assessment and diagnosis of heart failure , 1996, Journal of internal medicine.

[93] A. C. P. Barretto,et al. Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagnóstico e Tratamento da Insuficiência Cardíaca , 2002 .

[94] A. Burger,et al. Concomitant β-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure , 2002 .

[95] B. Chernow. Pulmonary Artery Flotation Catheters: A Statement by the American College of Chest Physicians and the American Thoracic Society , 1997 .

[96] Milton Packer,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[97] S. Hunt. Comment--the REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure. , 2002, Journal of cardiac failure.

[98] V. Shayani,et al. Intra-aortic balloon counterpulsation in patients with severe cardiac dysfunction undergoing abdominal operations. , 1998, Archives of surgery.

[99] J. Christenson,et al. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. , 2001, The Journal of invasive cardiology.

[100] Abdissa Negassa,et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[101] L. Goldman,et al. Preoperative assessment of patients with known or suspected coronary disease. , 1995, The New England journal of medicine.

[102] M. Gheorghiade,et al. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. , 2003, American heart journal.

[103] W. Zoghbi,et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.

[104] M. Kronenberg,et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. , 1993, Circulation.

[105] P. Mcdermott,et al. Effect of ED management on ICU use in acute pulmonary edema. , 1999, The American journal of emergency medicine.

[106] M. Packer,et al. Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. , 1986, Annals of internal medicine.

[107] O. Akinboboye. Prediction of improvement of regional left ventricular function after surgical revascularization. , 1996, Circulation.

[108] J. Ghali,et al. Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure , 2001 .

[109] F. Tristani,et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[110] G. Jennings,et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. , 1994, Journal of the American College of Cardiology.

[111] J. Cleland,et al. Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH , 2002, European journal of heart failure.

[112] N. Smedira,et al. Mechanical circulatory assistance: state of art. , 2002, Circulation.

[113] J. Heywood,et al. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic , 1997, Clinical cardiology.

[114] M. Anastasiou-Nana,et al. Effectiveness of amiodarone therapy in patients with severe congestive heart failure and intolerance to metoprolol. , 2002, The American journal of cardiology.

[115] W LUTZEYER,et al. [Blood transfusion]. , 1960, Blut.

[116] J. Masip,et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial , 2000, The Lancet.

[117] James T. Willerson,et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.

[118] S. Lipshultz,et al. Cardiomyocyte injury to transplant: pediatric management , 2003, Current opinion in cardiology.

[119] C. Jurkovitz,et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[120] J. Oh,et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. , 1998, Journal of the American College of Cardiology.

[121] T. Kaul,et al. Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. , 2000, Cardiovascular surgery.

[122] N. Freemantle,et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis , 2002, European journal of heart failure.

[123] D. Ascheim,et al. End-stage heart failure: which options? , 2002 .

[124] R. Buchhorn,et al. Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. , 1998, The American journal of cardiology.

[125] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[126] D. Johns,et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. , 2000, American journal of respiratory and critical care medicine.

[127] S. Rahimtoola,et al. Arterial Dilators in Mitral Regurgitation: Effects on Rest and Exercise Hemodynamics and Long‐term Clinical Follow‐up , 1982, Circulation.

[128] P A Heidenreich,et al. Prevention of hospitalizations for heart failure with an interactive home monitoring program. , 1998, American heart journal.

[129] S. Thomas,et al. A prospective study of complications of pulmonary artery catheterizations in 500 consecutive patients. , 1983, Chest.

[130] W. Browner,et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group. , 1992, JAMA.

[131] T. Albertson,et al. A multicenter study of physicians' knowledge of the pulmonary artery catheter. Pulmonary Artery Catheter Study Group. , 1990, JAMA.

[132] L. Resnekov. Aortic valve stenosis. Management in children and adults. , 1993, Postgraduate medicine.

[133] L. Cohn,et al. Hemodynamic Determinants of Prognosis of Aortic Valve Replacement in Critical Aortic Stenosis and Advanced Congestive Heart Failure , 1980, Circulation.

[134] B. Massie,et al. Optimizing therapy for complex or refractory heart failure: a management algorithm. , 1998, American heart journal.

[135] M. Rubenfire,et al. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a cooperative clinical trial , 1973 .

[136] Heart failure: A case for subspecialized care management. , 1999, American heart journal.

[137] H. Figulla,et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. , 1996, Journal of the American College of Cardiology.

[138] R. Lange,et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. , 2000, Journal of the American College of Cardiology.

[139] Z. Vered,et al. Acute heart failure: a novel approach to its pathogenesis and treatment , 2002, European journal of heart failure.

[140] L Goldman,et al. Factors contributing to the hospitalization of patients with congestive heart failure. , 1997, American journal of public health.

[141] S. D. De Hert,et al. Effect of preoperative beta-blockade on perioperative mortality in coronary surgery. , 2003, British journal of anaesthesia.

[142] E. Philbin,et al. Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction , 1999, Journal of the American Geriatrics Society.

[143] E. Bocchi,et al. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. , 2001, The Annals of thoracic surgery.

[144] V. Köllner,et al. Comparison of dobutamine and enoximone for low output states following cardiac surgery. , 1990, International journal of cardiology.

[145] J. Cleland,et al. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. , 1994, American heart journal.

[146] J. Hare,et al. Role of nitric oxide in the regulation of myocardial function. , 1995, Progress in cardiovascular diseases.

[147] J. Cohn,et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.

[148] R. Byrick,et al. The appropriateness of the pulmonary artery catheter in cardiovascular surgery , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[149] T. LeJemtel,et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. , 2000, The New England journal of medicine.

[150] D. McGiffin,et al. Predicting outcome after cardiac transplantations: lessons from the Cardiac Transplant Research Database. , 1997, Current opinion in cardiology.

[151] A. Pavie,et al. The Concerted Action 'Heart' European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. , 1997, European Journal of Cardio-Thoracic Surgery.

[152] N. Clausell,et al. Evidence for increased peripheral production of tumor necrosis factor-alpha in advanced congestive heart failure. , 2001, The American journal of cardiology.

[153] L. Goldman,et al. CARDIAC RISK FACTORS AND COMPLICATIONS IN NON‐CARDIAC SURGERY , 1978, Medicine.

[154] D R Nul,et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina. , 1997, Journal of the American College of Cardiology.

[155] Sankey V. Williams,et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). , 1999, Circulation.

[156] J. Heo,et al. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cardiomyopathy. , 1999, The American journal of cardiology.

[157] R. Maestri,et al. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. , 2002, Journal of the American College of Cardiology.

[158] D. Silverberg,et al. The importance of anemia and its correction in the management of severe congestive heart failure , 2002, European journal of heart failure.

[159] L. Way,et al. Monitoring for Myocardial Ischemia During Noncardiac Surgery: A Technology Assessment of Transesophageal Echocardiography and 12-Lead Electrocardiography , 1992 .

[160] F. Alla,et al. Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship , 2001, Hypertension.

[161] M. Nieminen,et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[162] D. Renlund,et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. , 1989, The Journal of heart transplantation.

[163] F. Zannad,et al. Clinical definition and epidemiology of advanced heart failure. , 1998, American heart journal.

[164] Blumer,et al. Pharmacology of inotropic agents in infants and children. , 2000, Progress in pediatric cardiology.

[165] A. Ferreira,et al. Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care , 2002, European journal of heart failure.

[166] W. Pinsky,et al. Grading the severity of congestive heart failure in infants , 1992, Pediatric Cardiology.

[167] M. Jessup,et al. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[168] N. Hollenberg. Control of renal perfusion and function in congestive heart failure. , 1988, The American journal of cardiology.

[169] L. Lenert,et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.

[170] M. Gheorghiade,et al. Vasopressin V 2-Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure Results From a Double-Blind , Randomized Trial , 2003 .

[171] Y. Moshkovitz,et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.

[172] Y. Moshkovitz,et al. Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure , 1997, Clinical pharmacology and therapeutics.

[173] John V. Wylie,et al. Nesiritide for the treatment of decompensated heart failure , 2004, Expert review of cardiovascular therapy.

[174] N. Smedira,et al. Balloon aortic valvuloplasty as a bridge to aortic valve replacement in critically ill patients. , 1993, The Annals of thoracic surgery.

[175] E. Blackstone,et al. Pulmonary vascular resistance and the risk of heart transplantation. , 1988, The Journal of heart transplantation.

[176] W. Gaasch,et al. The management of mitral valve disease. , 1996, Current opinion in cardiology.

[177] T. LeJemtel,et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. , 2002, American heart journal.

[178] R. Feneck,et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. , 2001, Journal of cardiothoracic and vascular anesthesia.

[179] P. Brugada,et al. "Tachycardiomyopathy". The most frequently unrecognized cause of heart failure? , 1993, Acta cardiologica.

[180] Thomas Lavergne,et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[181] C. Kawai,et al. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. , 1980, British heart journal.

[182] S. Stewart,et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. , 1999, Archives of internal medicine.

[183] S Capewell,et al. Substantial between-hospital variation in outcome following first emergency admission for heart failure. , 2002, European heart journal.

[184] P. Ponikowski,et al. Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.

[185] E D Freis,et al. Hemodynamic changes during sleep. , 1967, Journal of applied physiology.

[186] Forrest Ap,et al. The impact of intraoperative transoesophageal echocardiography on an unselected cardiac surgical population: a review of 2343 cases. , 2002 .

[187] N. Takahashi,et al. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. , 1998, The Journal of clinical investigation.

[188] S. Kaul,et al. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. , 1999, Journal of the American College of Cardiology.

[189] G. Daskalopoulos,et al. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. , 1987, Gastroenterology.

[190] L. Stevenson. Heart transplant centers: no longer the end of the road for heart failure. , 1996, Journal of the American College of Cardiology.

[191] R. Gibbons,et al. Guidelines for the Management of Patients With Valvular Heart Disease Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease) , 1998 .

[192] L. Morrison,et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea ☆ , 2002 .

[193] V. Froelicher,et al. Management of the patient with congestive heart failure using outpatient, home, and palliative care. , 2000, Progress in cardiovascular diseases.

[194] U. Ikeda,et al. The coagulation system is activated in idiopathic cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[195] K. Swedberg,et al. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. , 1985, The American journal of medicine.

[196] D. Sica. ACE Inhibitors and Anemia in Congestive Heart Failure , 2000 .

[197] H. Doval,et al. Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). , 1999, The American journal of cardiology.

[198] W. Ghali,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. , 1997, The New England journal of medicine.

[199] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[200] Paul W Armstrong,et al. Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[201] Michel Haissaguerre,et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. , 2002, The American journal of cardiology.

[202] R. Cody. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? I. Introduction. , 1988, Journal of the American College of Cardiology.

[203] I. Klein,et al. Editorial: Thyroid Hormone-Targeting the Heart. , 2001, Endocrinology.

[204] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[205] J. Gore,et al. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2002, The American journal of cardiology.

[206] C. Henschke,et al. Pathophysiology of Chest Pain in Patients with Cardiomyopathies and Normal Coronary Arteries , 1982, Circulation.

[207] W. Stevenson,et al. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. , 1995, American heart journal.

[208] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[209] W. Gaasch. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. , 1994, JAMA.

[210] L. Sleeper,et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. , 2001, American heart journal.

[211] M. Gotsman,et al. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.

[212] C. Polanczyk,et al. Ten-year trends in hospital care for congestive heart failure: improved outcomes and increased use of resources. , 2000, Archives of internal medicine.

[213] Jeroen J. Bax,et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[214] J. Cleland,et al. Diastolic heart failure: neglected or misdiagnosed? , 2002, Journal of the American College of Cardiology.

[215] D. Schwartz,et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[216] 堀正二,et al. Cardiac mechanics and function in the normal and diseased heart , 1989 .

[217] L. Goldman,et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. , 1998, Circulation.

[218] T. Douglas Bradley,et al. Sleep Apnea and Heart Failure: Part I: Obstructive Sleep Apnea , 2003, Circulation.

[219] J. Cleland,et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.

[220] J S Floras,et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. , 1999, American journal of respiratory and critical care medicine.

[221] S. Rahimtoola,et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. , 1994, The New England journal of medicine.

[222] S. Anker,et al. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. , 2002, International journal of cardiology.

[223] A. Skene,et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.

[224] S. Goldsmith. Vasopressin: a therapeutic target in congestive heart failure? , 1999, Journal of cardiac failure.

[225] C. Leier,et al. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. , 1984, Circulation.

[226] G. Beller,et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. , 1997, Circulation.

[227] J. V. Nixon,et al. Furosemide absorption altered in decompensated congestive heart failure. , 1985, Annals of internal medicine.

[228] S. Hunt,et al. The REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure , 2002 .

[229] J. Schroeder,et al. Accelerated graft coronary artery disease in heart-transplant recipients. , 1995, Coronary artery disease.

[230] Acute congestive heart failure. The need for aggressive therapy. , 1997, Postgraduate medicine.

[231] R. Califf,et al. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.

[232] M. Pfeffer,et al. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial , 2000, The Lancet.

[233] P. White,et al. Effect of preoperative β‐blockade on perioperative mortality in coronary surgery , 2003 .

[234] P. Poole‐Wilson,et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy , 1998, The Lancet.

[235] W. Kannel,et al. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[236] L. Stevenson,et al. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. , 1999, American heart journal.

[237] I. Shapira,et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[238] W. Rand,et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[239] J. Arnold,et al. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. , 2002, American heart journal.

[240] Mark A. Hlatky,et al. Guidelines for the Evaluation and Management of Heart Failure Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) , 1995 .

[241] E. Espiner,et al. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. , 1980, Clinical science.

[242] H. Kehlet,et al. Prediction of cardiac risk in non-cardiac surgery. , 1987, European heart journal.

[243] E. Antman,et al. Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[244] M. Maurer,et al. Pathophysiology of Heart Failure , 2007 .

[245] D. Kitzman,et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. , 1999, Journal of the American College of Cardiology.

[246] Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). , 1995, Circulation.

[247] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[248] J H Patterson,et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. , 1996, Journal of the American College of Cardiology.

[249] Arantxa González,et al. Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients , 2002, Circulation.

[250] J. Cleland,et al. Levosimendan: a new era for inodilator therapy for heart failure? , 2002, Current opinion in cardiology.

[251] J. Cleland,et al. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. , 1991, Journal of the American College of Cardiology.

[252] J. Ramires,et al. Eight‐year experience of pediatric heart transplantation: Clinical outcome using  non‐invasive methods for the evaluation  of acute rejection , 2002, Pediatric transplantation.

[253] P. Poole‐Wilson,et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. , 2001, Journal of the American College of Cardiology.

[254] M. Rich,et al. Early Readmission of Elderly Patients With Congestive Heart Failure , 1990, Journal of the American Geriatrics Society.

[255] V. Tapson,et al. Venous thromboembolism in intensive care patients. , 2003, Clinics in chest medicine.

[256] N. Boon,et al. Thyroid disease and the heart , 2000, Heart.

[257] G. Reeder. Heart Disease: A Textbook of Cardiovascular Medicine , 1984 .

[258] F. Alla,et al. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.

[259] A. Maggioni,et al. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). , 2002, European heart journal.

[260] J. Cleland,et al. Intravenous levosimendan treatment is cost‐effective compared with dobutamine in severe low‐output heart failure: an analysis based on the international LIDO trial , 2003, European journal of heart failure.

[261] R. Debusk,et al. Disease management systems for chronic cardiovascular diseases: focus on heart failure. , 2001, Advances in internal medicine.

[262] R. Štípal,et al. Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction , 1999 .

[263] P. LaVeau,et al. Interobserver variability in the interpretation of pulmonary artery catheter pressure tracings. , 1991, Chest.

[264] T Douglas Bradley,et al. Sleep Apnea and Heart Failure: Part II: Central Sleep Apnea , 2003, Circulation.

[265] M. Luu,et al. Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.

[266] M. Grinberg,et al. Gravidez em Portadoras de Cardiomiopatia Periparto. Estudo Prospectivo e Comparativo , 2002 .

[267] R. Page,et al. Biventricular Pacing Decreases Sympathetic Activity Compared With Right Ventricular Pacing in Patients With Depressed Ejection Fraction , 2000, Circulation.

[268] K. Ellenbogen,et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.

[269] H. S,et al. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .

[270] J E Parrillo,et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.

[271] M. Domanski,et al. Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction). , 1999, The American journal of cardiology.

[272] P. Batin,et al. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. , 1995, European heart journal.

[273] J. Cohn,et al. Incidence of Thromboembolic Events in Congestive Heart Failure , 1993, Circulation.

[274] P. Iversen,et al. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[275] R. Vasan,et al. Defining diastolic heart failure: a call for standardized diagnostic criteria. , 2000, Circulation.

[276] P. Choban,et al. A prospective randomized trial of preoperative "optimization" of cardiac function in patients undergoing elective peripheral vascular surgery. , 1997, Surgery.

[277] R. Califf,et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[278] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[279] Catherine M. Otto,et al. Evaluation and Management of Chronic Mitral Regurgitation , 2001 .

[280] P. Macdonald,et al. Optimization of left ventricular function with carvedilol before high-risk cardiac surgery. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[281] W. Braham,et al. Cardiac Resynchronization in Chronic Heart Failure , 2002 .

[282] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[283] Jeroen J. Bax,et al. Perfusion and Contractile Reserve in Chronic Dysfunctional Myocardium: Relation to Functional Outcome After Surgical Revascularization , 2002, Circulation.

[284] J. Ramires,et al. Tratamento ambulatorial de rejeição persistente com methotrexate em pacientes submetidos a transplante cardíaco estáveis clinicamente , 2000 .

[285] K. Swedberg,et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[286] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[287] L. J. Groot,et al. Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .

[288] R. Maestri,et al. Chronic infusion of dobutamine and nitroprusside in patients with end‐stage heart failure awaiting heart transplantation: safety and clinical outcome , 2001, European journal of heart failure.

[289] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[290] M. Levy,et al. Frequency of mortality and myocardial infarction during maximizing oxygen delivery: a prospective, randomized trial. , 1995, Critical care medicine.

[291] P. Rigo,et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[292] A. Philip,et al. History, definition, and classification of heart failure , 1997 .

[293] Guadalajara Boo Jf,et al. [What is heart failure?]. , 1998, Archivos del Instituto de Cardiologia de Mexico.

[294] A. Forrest,et al. The Impact of Intraoperative Transoesophageal Echocardiography on an Unselected Cardiac Surgical Population: A Review of 2343 Cases , 2002, Anaesthesia and intensive care.

[295] A D Bersten,et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. , 1991, The New England journal of medicine.

[296] M. Domanski,et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. , 1997, Journal of the American College of Cardiology.

[297] C. Lang,et al. Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.

[298] R. Nishimura,et al. Clinical assessment and management of mitral stenosis. , 1998, Cardiology clinics.

[299] R. Magorien,et al. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.

[300] A. Jatene,et al. Low doses of inhaled nitric oxide in heart transplant recipients. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[301] L. Stevenson,et al. Medical management of advanced heart failure. , 2002, JAMA.

[302] J. Gardin,et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. , 2001, The American journal of cardiology.

[303] R. Troughton,et al. NT‐proBNP in heart failure: therapy decisions and monitoring , 2004, European journal of heart failure.

[304] G. Fonarow,et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[305] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[306] J. Bender,et al. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial. , 1997, Annals of surgery.

[307] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[308] D. Brutsaert,et al. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[309] M. Nieminen,et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). , 2002, European heart journal.

[310] Jeroen J. Bax,et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. , 1997, Journal of the American College of Cardiology.

[311] R. Mills,et al. Non-cardiac surgery in the heart failure patient , 2001, Heart.

[312] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[313] C. Kawai,et al. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[314] J. Vincent,et al. Expert Panel: The use of the pulmonary artery catheter , 2005, Intensive Care Medicine.

[315] A. Iranmanesh,et al. Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure. , 2001, Journal of cardiac failure.

[316] A. Hassid,et al. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[317] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[318] Samuel Wann,et al. [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[319] W. Kao,et al. Management of acute heart failure exacerbation. , 2001, Critical care clinics.

[320] B. Jugdutt,et al. Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction. , 1994, Circulation.

[321] R. Hetzer,et al. Prognosis After the Implantation of an Intra-Aortic Balloon Pump in Cardiac Surgery Calculated With a New Score , 2002, Circulation.

[322] M. Rich. Multidisciplinary interventions for the management of heart failure: where do we stand? , 1999, American heart journal.

[323] J. Sackner-Bernstein,et al. Is there risk associated with the use of nesiritide for acute heart failure , 2003 .

[324] L. Tavazzi,et al. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. , 1996, European heart journal.

[325] J. Ghali,et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. , 2002, Journal of the American College of Cardiology.

[326] Z. Vered,et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. , 2000, Journal of the American College of Cardiology.

[327] N. Alpert,et al. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics. , 1995, Journal of cardiovascular pharmacology.

[328] R. Popp,et al. Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[329] P. Oettgen,et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. , 1995, Journal of the American College of Cardiology.

[330] P. Brugada,et al. Tachycardiomyopathy: Mechanisms and Clinical Implications , 1996, Pacing and clinical electrophysiology : PACE.

[331] L. Stevenson,et al. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[332] M. Janse,et al. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[333] B. Reichart,et al. Role of dobutamine stress echocardiography for diagnosis of cardiac allograft vasculopathy. , 1998, Transplantation proceedings.

[334] G. Ethévenot,et al. Early and long-term outcome after emergency coronary artery bypass surgery after failed coronary angioplasty. , 1991, Circulation.

[335] A S Detsky,et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. , 1986, Archives of internal medicine.

[336] B. McManus,et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[337] M. Gheorghiade,et al. Vasopressin V2-Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure: Results From a Double-Blind, Randomized Trial , 2003, Circulation.

[338] R. Habib,et al. Safe, highly selective use of pulmonary artery catheters in coronary artery bypass grafting: an objective patient selection method. , 2002, The Annals of thoracic surgery.

[339] S. Siu,et al. Intra-aortic balloon counterpulsation support in the high-risk cardiac patient undergoing urgent noncardiac surgery. , 1991, Chest.

[340] M. Bristow,et al. Inotropes and beta-blockers: is there a need for new guidelines? , 2001, Journal of cardiac failure.

[341] P. Denes,et al. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. , 1996, American heart journal.

[342] Marc A Pfeffer,et al. New therapeutic options in congestive heart failure: Part I. , 2002, Circulation.

[343] R. Bonow,et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.

[344] G. Hasenfuss,et al. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. , 1998, Circulation.

[345] S. Frøland,et al. Effect of thalidomide in patients with chronic heart failure. , 2002, American heart journal.

[346] B. Schnackenburg,et al. Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[347] L. D. De Groot. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[348] G. Morris,et al. Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.

[349] R. O'rourke,et al. The diagnosis and management of acute left-sided valvular regurgitation. , 1979, Current problems in cardiology.

[350] M. Scanavacca,et al. Diretrizes para Avaliação e Tratamento de Pacientes com Arritmias Cardíacas , 2002 .

[351] D. Levy,et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[352] A. Levin,et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[353] Harlan M Krumholz,et al. The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.

[354] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[355] P. Binkley,et al. Parenteral inotropic support for advanced congestive heart failure. , 1998, Progress in cardiovascular diseases.

[356] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[357] M. Bristow,et al. Inotropes and β-blockers: Is there a need for new guidelines? , 2001 .

[358] C M O'Connor,et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[359] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[360] M. Holzer,et al. Intra-aortic balloon counterpulsation in the emergency department: a 7-year review and analysis of predictors of survival. , 2002, Resuscitation.

[361] N. Sheynberg,et al. Effect of Heart Failure Program on Cardiovascular Drug Utilization and Dosage in Patients with Chronic Heart Failure , 2000, Clinical cardiology.

[362] J. Mann,et al. What are the short-term and long-term consequences of anaemia in CRF patients? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[363] D. King,et al. Fat malabsorption in elderly patients with cardiac cachexia. , 1996, Age and ageing.

[364] A. Della Corte,et al. Coronary Artery Bypass Grafting in Patients with Severe Left Ventricular Dysfunction: A Prospective Randomized Study on the Timing of Perioperative Intraaortic Balloon Pump Support , 2002, The International journal of artificial organs.

[365] M. Otaki. Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality. , 1994, Chest.